title: The pricing of pharmaceuticals: an international comparison.
abstract: Four types of pricing policies and regulations are recognized: product price control, as practiced in France, Italy, Portugal, and Spain; reference pricing, as in Germany and the Netherlands; profit control, as in the United Kingdom; and no control, as in the United States. The system in Canada is a hybrid of product price control and reference pricing; a producer may set any price for a new product as long as it is within guidelines established by a federal government review board. The implications of each system are discussed. Various prescription reimbursement policies are used to control consumer and government expenditures for drugs. Expenditure is a function of many factors, including price, consumption patterns, reimbursement policies, and social, economic, and political values.
authors.affiliation: College of Pharmacy, University of South Carolina, Columbia.
authors.forename: M
authors.initials: M
authors.lastname: Dickson
mesh_terms: D002170:Canada; D017047:Cost Sharing; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions / Q000191:economics*; D005060:Europe; D005252:Fees, Pharmaceutical; D006291:Health Policy; D007349:Insurance, Health, Reimbursement; D006113:United Kingdom; D014481:United States